Lumbar Ureteral Stenosis due to Endometriosis: Our Experience and Review of the Literature

Table 1

Tumour markers and hormonal levels.

Analyte	Value	Normal range
Tumour markers values
CA 125 (cancer antigen 125)	21,84 UI/mL	0–33 UI/mL
CA 19.9 (cancer antigen 19.9)	8,25 UI/mL	0–40 UI/mL
CEA (carcinoembryonic antigen)	0,46 ug/mL	Nonsmoker (as was the patient): 0–3 ug/mL.
AFP (alpha-fetoprotein)	0,97 ng/mL	0–7,5 ng/mL
Hormonal levels
FSH (follicle stimulating hormone)	4.46 mIU/mL	Follicular phase (as was the patient): 3,5–12,5 mIU/mL
LH (luteinizing hormone)	3.04 mIU/mL	Follicular phase (as was the patient): 2,4–12,6 mIU/mL
E2 (17 β estradiol)	227 pg/mL	Follicular phase (as was the patient): 12,5–166 pg/mL
PG (progesterone)	0,70 ng/mL	Follicular phase (as was the patient): 0,2–1,5 ng/mL
β-HCG (β-human chorionic gonadotropin)	Negative